Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium hyaluronate (Avizor)
- Development stage
- Unknown
- Lead developer
- Avizor
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
AVIZOR LACRIFRESH is a brand of lubricating ophthalmic solutions (artificial tears) developed by the Spanish company Avizor and distributed in various markets, including Vietnam by TV TPI. The product line is primarily designed to alleviate symptoms of dry eye syndrome, ocular irritation, and eye fatigue caused by environmental factors, prolonged screen use, or contact lens wear. The flagship formulation, Lacrifresh Moisture, contains 0.1% sodium hyaluronate, a naturally occurring viscoelastic polysaccharide that mimics the properties of the natural tear film to stabilize the precorneal layer and provide long-lasting hydration. Other variants in the line include Lacrifresh Comfort (containing povidone) and Lacrifresh Ocu-Dry (containing higher concentrations of sodium hyaluronate, such as 0.2% or 0.3%). These products are often registered as medical devices or over-the-counter pharmaceutical lubricants depending on the jurisdiction.
- Brand names
- AVIZOR LACRIFRESHLacrifresh MoistureLacrifresh ComfortLacrifresh Ocu-Dry
- Other names
- hyaluronic acidsodium hyaluronate ophthalmic
02
Targets
CD44 (CD44 antigen)Ocular surface mucin layerFibrin (Factor Ia)
Beyond the preview
Go deeper on sodium hyaluronate (Avizor).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium hyaluronate (Avizor).